Svenja Ryczek-Wagener
Kerpener Str. 62
Koeln, NW 50937, Germany
Koeln, NW 50937, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Pitfalls in Detecting MET Exon 14 Skipping Variants by DNA- and RNA-Based Next-Generation Sequencing Technologies in a Large Real-World Cohort and Results of the First Multinational External Quality Assessment Schemes.
Journal: The Journal of molecular diagnostics : JMD
Published: February 11, 2026
Pitfalls in Detecting MET Exon 14 Skipping Variants by DNA- and RNA-Based Next-Generation Sequencing Technologies in a Large Real-World Cohort and Results of the First Multinational External Quality Assessment Schemes.
Journal: The Journal of molecular diagnostics : JMD
Published: February 11, 2026
Dessicating stress triggers and exacerbates experimental ocular Graft-versus-host-disease.
Journal: The ocular surface
Published: February 06, 2025
CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.
Journal: Cancer cell
Published: August 25, 2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score.
Journal: NPJ precision oncology
Published: March 18, 2024
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 25, 2023
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 14, 2023
Differentially expressed messenger RNA/proteins can distinguish teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection tissue.
Journal: Cancer
Published: August 15, 2022
Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 03, 2022
Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue.
Journal: Virchows Archiv : an international journal of pathology
Published: April 01, 2022
Targeted RNA-sequencing for the evaluation of gene fusions in lung tumors: current status and future prospects.
Journal: Expert review of molecular diagnostics
Published: April 22, 2021
Biomarkers for Homologous Recombination Deficiency in Cancer.
Journal: Journal of personalized medicine
Published: April 19, 2021
Last Updated: 09/26/2026